8th Disease Maps Community Meeting

When: 25/03/2024 - 27/03/2024
Where: University of Luxembourg, Campu Belval, Maison du Savoir 2, avenue de l’Université, L-4365 Esch-sur-Alzette, Luxembourg
A joint event of the Disease Maps Community and the ELIXIR Systems Biology Community

The Disease Maps Project as a large-scale community effort was initiated by the Luxembourg Centre for Systems Biomedicine, the European Institute for Systems Biology and Medicine and the Institut Curie.

We are actively expanding the list of diseases covered by the Disease Maps Project and are looking for new contributors interested in molecular mechanisms of diseases: computational biology teams working on disease models and clinicians or experimental biologists who would like to contribute as domain experts.

Abstract Submission Deadline: 24 January 2024

Registration Deadline: 2 March 2024

More info HERE


Tag: | Events: 339 of 362
All events

News

  • 02/05/2024

    Unveiling the Future: Highlights from the FDA/MDIC Symposium on Computational Modeling and Simulation (CM&S) in Washington D.C.

    • The FDA/MDIC Symposium on Computational Modeling and Simulation (CM&S) in Washington DC (April 15-17, 2024) unfolded its vibrant tapestry for three enlightening days of interdisciplinary innovation and collaboration. -Read more-
  • 30/04/2024

    Council releases Draft Conclusions on Horizon 2020 evaluation

    • The Council of the European Union highlighted the significance of Horizon 2020 in bolstering the EU's competitiveness in its Draft Conclusions regarding the ex-post evaluation of the research and innovation funding program. -Read more-
  • 30/04/2024

    WHO introduces cutting-edge digital health advocate utilizing generative AI for public health

    • The World Health Organization (WHO) announces the debut of S.A.R.A.H., a prototype digital health advocate equipped with an enhanced empathetic interface driven by generative artificial intelligence (AI). -Read more-
  • 30/04/2024

    EFPIA advocates for responsible AI use in medicine development

    • The European Federation of Pharmaceutical Industries and Associations (EFPIA) underlines the potential benefits of employing Artificial Intelligence (AI) in advancing patient care, fostering innovation, and benefiting society at large. -Read more-
More news

Events

More events
newsletter

Subscribe to the VPH Institute Newsletter

ARCHIVE

Read all the newsletters of the VPH Institute

GO